Frankfurt Rights

Your Search Results

      Filter your results
      Filter your results
      • Events
      • Category
      • Seller
      • Publication Year
      • Original Language
      • Rights Available in Language
      • Publish Status
      • Publication Country or region
      • Rights Available in Territory
      • Offer Type
      • Permission selling companies
      • More
      View items
      • Trusted Partner
        Complications in Non-vascular Interventional Therapy and Interventional Oncology: Case-based Solutions
        June 2019

        Complications in Non-vascular Interventional Therapy and Interventional Oncology: Case-based Solutions

        by Müller-Hülsbeck, Stefan; Jahnke, Thomas

        More
      • Trusted Partner
        Oral Health and Oral Care
        Health & Personal Development

        Oral Health and Oral Care

        Practice Manual for Nurses, Nursing, Dental and Dental Prophylaxis Assistants

        by Thomas Gottschalck

        A healthy, cared­for mouth prevents the occurrence of oral diseases and systemic contingent diseases. Every day, professional hygienists are con­fronted with the oral care of their pa­tients and need to be informed of new developments in dentistry, pharmacol­ogy, technology, and care methods. This book offers sound action recom­mendations for hygienists and dental assistants with vivid illustrations. There are clear descriptions of the anatomical and physiological basics of oral mucosa, teeth, and the oral cavity ecosystem. Practical illustrations of the connections between oral health and general health, debilitating risks, handling modern den­tures, assessment of oral changes, oral approaches through basal stimulation and dietary recommendations are pro­vided. Consideration is also given to oral hygiene in special settings, for example, in the case of neurological, psychologi­cal, or mental impairments as well as people receiving geriatric, oncological, intensive, or palliative care.

        More
      • Trusted Partner
        Personalised cancer medicine
        Medicine
        January 2021

        Personalised cancer medicine

        by Anne Kerr, Choon Key Chekar, Emily Ross, Julia Swallow, Sarah Cunningham-Burley

        More
      • Trusted Partner
        Interactions between Medicines and Food
        2020

        Interactions between Medicines and Food

        by Prof. Dr. Martin Smollich and Dr. Julia Podlogar

        Interactions between medicines and foodstuffs may be just as clinically relevant as interactions between individual drugs. A single meal contains several hundred potentially interacting compounds that, in an individual patient, may be the deciding factor as to whether a treatment is successful or not. The resulting, sometimes serious risks are not known to most patients – nor to many physicians and pharmacists. This practical handbook enables anyone interested in applied pharmacotherapy to keep abreast of the complex field of drug interactions. The authors – proven experts in clinical pharmacology and pharmaconutrition – describe the most important interactions and give concrete recommendations for action. Tables and overviews permit fast access to potentially problematic combinations. This completely updated edition now also includes information about fruit juices and curcumin as well as a new chapter on food interactions in oncology.

        More
      • Trusted Partner
        Science, Being, & Becoming
        Mind, Body, Spirit

        Science, Being, & Becoming

        The Spiritual Lives of Scientists

        by Paul J. Mills, Ph.D.

        Spirituality is the Final Frontier for ScienceContrary to popular belief, not all scientists are materialists fervently discounting the spiritual. Science, Being, & Becoming is about the spiritual lives of scientists, their actual transpersonal, metaphysical and mystical experiences. The book's material is derived from intimate interviews with over 30 scientists as they describe the circumstances under which they had the experiences and how those experiences changed their consciousness, transformed their belief systems about the nature of the world, and changed their scientific work.

        More
      • Implementing a National Cancer Clinical Trials System for the 21st Century
        Health systems & services
        September 2011

        Implementing a National Cancer Clinical Trials System for the 21st Century

        Workshop Summary

        by Alison Mack and Sharyl J. Nass, Rapporteurs; National Cancer Policy Forum; Institute of Medicine; An American Society of Clinical Oncology and Institute of Medicine Workshop

        Clinical trials enable scientific discoveries to advance patient care, in addition to informing and guiding subsequent research. The National Cancer Institute's (NCI's) Clinical Trials Cooperative Group Program works to advance patient care and research. The Cooperative Group Program has been instrumental in establishing the standards for cancer patient care and clinical research methods. Despite broad participation in the program, financial strain and procedural burdens limit the ability of the Cooperative Group Program to undertake medical practice-changing clinical research. Thus, the Institute of Medicine's (IOM's) National Cancer Policy Forum and the American Society of Clinical Oncology held a workshop on March 21, 2011 to follow up on the 2010 IOM report, A National Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program, which made recommendations to strengthen the NCI Cooperative Group Program. In keeping with the established commitment to excellence Implementing a National Cancer Clinical Trials System for the 21st Century outlines how to improve the current system by incorporating innovative science and trial design into cancer clinical trials. It also examines the impact of increasing quality in regards to speed, efficiency, design, launch, and conduct, as well as improving prioritization, and incentivized participation.

        More
      • Complex General Surgical Oncology: a Case-Based Approach (Volume 2)
        Surgical oncology
        November 2013

        Complex General Surgical Oncology: a Case-Based Approach (Volume 2)

        by Jason B Fleming, Daniel E Abbott

        Surgical oncology is a rapidly evolving field. Through increasingly sophisticated technologies and interventional techniques, and continued basic science breakthroughs, care of the cancer patient is ever improving. A cornerstone of this improvement is a continual evaluation and recognition of evidence-based changing practice patterns. This reality forms the basis for this two-volume text, focusing on diagnostic and treatment algorithms to maximize quality care for the surgical oncology patient. To engage the reader with real-world, patient-centered learning, this book consists of case-based scenarios and follow-up questions addressing key concepts of complex surgical oncology. This first volume of 18 chapters focuses on a variety of breast pathology, followed by examination of endocrine, soft tissue and esophageal malignancies, providing an excellent resource to guide optimal care for patients.

        More
      • Complex General Surgical Oncology: a Case-Based Approach (Volume 1)
        Surgical oncology
        November 2013

        Complex General Surgical Oncology: a Case-Based Approach (Volume 1)

        by Jason B Fleming, Daniel E Abbott

        Surgical oncology is a rapidly evolving field. Through increasingly sophisticated technologies and interventional techniques, and continued basic science breakthroughs, care of the cancer patient is ever improving. A cornerstone of this improvement is a continual evaluation and recognition of evidence-based changing practice patterns. This reality forms the basis for this two-volume text, focusing on diagnostic and treatment algorithms to maximize quality care for the surgical oncology patient. To engage the reader with real-world, patient-centered learning, this book consists of case-based scenarios and follow-up questions addressing key concepts of complex surgical oncology. This first volume of 18 chapters focuses on a variety of breast pathology, followed by examination of endocrine, soft tissue and esophageal malignancies, providing an excellent resource to guide optimal care for patients.

        More
      • Nanotechnology and Oncology
        Oncology
        July 2011

        Nanotechnology and Oncology

        Workshop Summary

        by Margie Patlak and Christine Micheel, Rapporteurs; National Cancer Policy Forum; Board on Health Care Services; Institute of Medicine

        One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts.

        More
      • Monoclonal Antibodies in Oncology
        Oncology
        April 2013

        Monoclonal Antibodies in Oncology

        by Fatih M Uckun

        Monoclonal antibodies (mAbs) have been developed to improve the treatment outcome of cancer patients undergoing therapy according to multimodality regimens without a significant increase of treatment-associated toxicity. This five-chapter book provides examples where mAbs that have become part of the standard of care in cancer patients and cancer types that have responded to mAbs. Individual chapters devoted to each target cancer type illustrate the importance of recognizing and leveraging the unique features of the respective mAb in order to fully realize their therapeutic potential.

        More
      • Drug Delivery in Oncology

        Drug Delivery in Oncology

        by Alex D Ricart

        More
      • Trusted Partner
        Therapeutic Strategies in Veterinary Oncology
        Medicine
        April 2023

        Therapeutic Strategies in Veterinary Oncology

        by Chand Khanna, Nicole Amato, Jacob Cawley, Steven Dow, Joelle Fenger, Andi Flory, Ira Gordon, Kayla Harding, Kelvin Kow, Cheryl London, Nicola Mason, Arata Matsuyama, Jonathan Mochel, Anthony Mutsaers, Henrik Rönnberg, Wesley Wierson

        This book is a comprehensive resource for veterinary oncologists and trainees, covering therapeutic strategies used in the treatment of veterinary patients. In the setting of a rapidly changing field like oncology, this timely text focuses on mechanisms of action and biological rationale rather than current specific clinical recommendations, allowing current and future clinicians to adapt treatment approaches as our understanding of the biology of cancer evolves. With each chapter written by experts in their field, this book provides informative figures that convey this biological understanding and rationale of therapy. It starts from the mechanisms of treatment as we currently understand them, covering radiation therapy, chemotherapy options, enzyme therapy, gene editing, inhibitors, and many more. Dispensing vital, detailed and practical information about the different therapeutic strategies available, this book is a vital resource for practicing veterinarians, while also providing students of veterinary oncology with a better understanding of the key differences between different treatment strategies.

        More
      • Ensuring Quality Cancer Care Through the Oncology Workforce
        Oncology
        April 2009

        Ensuring Quality Cancer Care Through the Oncology Workforce

        Sustaining Care in the 21st Century: Workshop Summary

        by Margie Patlak and Laura Levit, Rapporteurs

        The American Society of Clinical Oncology (ASCO) predicts that by 2020, there will be an 81 percent increase in people living with or surviving cancer, but only a 14 percent increase in the number of practicing oncologists. As a result, there may be too few oncologists to meet the population's need for cancer care. To help address the challenges in overcoming this potential crisis of cancer care, the National Cancer Policy Forum of the Institute of Medicine (IOM) convened the workshop Ensuring Quality Cancer Care through the Oncology Workforce: Sustaining Care in the 21st Century in Washington, DC on October 20 and 21, 2008.

        More
      • Implementing a National Cancer Clinical Trials System for the 21st Century
        Oncology
        September 2013

        Implementing a National Cancer Clinical Trials System for the 21st Century

        Second Workshop Summary

        by An American Society of Clinical Oncology and Institute of Medicine Workshop; Sharyl J. Nass and Margie Patlak, Rapporteurs; National Cancer Policy Forum; Board on Health Care Services; Institute of Medicine

        The National Clinical Trials Network (NCTN) supported by the National Cancer Institute (NCI) has played an integral role in cancer research and in establishing the standard of care for cancer patients for more than 50 years. Formerly known as the NCI Clinical Trials Cooperative Group Program, the NCTN is comprised of more than 2,100 institutions and 14,000 investigators, who enroll more than 20,000 cancer patients in clinical trials each year across the United States and internationally. Recognizing the recent transformative advances in cancer research that necessitate modernization in how cancer clinical trials are run, as well as inefficiencies and other challenges impeding the national cancer clinical trials program, the NCI asked the IOM to develop a set of recommendations to improve the federally funded cancer clinical trials system. These recommendations were published in the 2010 report, A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. In early 2011, the NCPF and the American Society of Clinical Oncology (ASCO) held a workshop in which stakeholders discussed the changes they planned to implement in response to the IOM goals and recommendations. Two years later, on February 11-12, 2013, in Washington, DC, the NCPF and ASCO reconvened stakeholders to report on the changes they have made thus far to address the IOM recommendations. At this workshop, representatives from the NCI, the NCTN, comprehensive cancer centers, patient advocacy groups, the Food and Drug Administration (FDA), industry, and other stakeholders highlighted the progress that has been made in achieving the goals for a reinvigorated national cancer clinical trials system. Implementing a National Cancer Clinical Trials System for the 21st Century is a summary of that workshop.

        More
      • Fast Facts: Gynecologic Oncology
        Gynaecology & obstetrics
        January 2010

        Fast Facts: Gynecologic Oncology

        by Shohreh Shahabi, J Richard Smith, Giuseppe Del Priore

        Gynecologic tumors that have a low incidence are seen infrequently by the non-specialist, but nevertheless require prompt recognition and management to minimize their potentially devastating effects.Fast Facts: Gynecologic Oncology has been written by three eminent specialists to provide the family physician and the non-specialist with a concise guide to these tumors to aid recognition, selection of management strategy and likely prognosis. Table of contents: Cervical cancer Endometrial cancer Ovarian cancer Vulval cancer Gestational trophoblastic neoplasia Pain management and palliation Future trends

        More
      • Journal of Pediatric Hematology / Oncology
        Medicine
        1979

        Journal of Pediatric Hematology / Oncology

        by Edited by Barton A Kamen MD

        8 issues/yr - 2013 Volume(s) - 33 www.jpho-online.com The Journal of Pediatric Hematology / Oncology reports on major advances in the diagnosis and treatment of cancer and blood diseases in children. Each issue presents informative case studies and original research articles from leading clinicians and investigators worldwide. Also featured are Clinical and Laboratory Observations that provide practical insights into pertinent issues.

        More
      • American Journal of Clinical Oncology
        Medicine
        1978

        American Journal of Clinical Oncology

        Cancer Clinical Trials

        by Edited by David E Wazer MD

        Bimonthly - 2013 Volume(s) - 34 www.amjclinicaloncology.com The American Journal of Clinical Oncology is a multidisciplinary journal for cancer surgeons, radiation oncologists, medical oncologists, gynecologic oncologists, and pediatric oncologists. Under the leadership of David E. Wazer, MD, the journal focuses on combined modality multidisciplinary loco-regional management of cancer. The journal also gives emphasis to translational research, outcome studies, and cost utility analyses, and includes opinion pieces and review articles. Published Bimonthly

        More
      • Current Opinion in Oncology
        Medicine
        1989

        Current Opinion in Oncology

        by Edited by Jean Klastersky

        Bimonthly - 2013 Volume(s) - 23 www.co-oncology.com With its easy-to-digest reviews on important advances in world literature, Current Opinion in Oncology offers expert evaluation on a wide range of topics from seventeen key disciplines including sarcomas, transplantation, cancer biology and endocrine tumors. Published bimonthly, each issue covers in detail the most pertinent advances in these fields from the previous year. This is supplemented by an in-depth bibliography gleaned from several hundred top journals in the field, complete with annotations detailing the merits of the most important papers.

        More

      Subscribe to our

      newsletter

      Powered by:

      (c) Copyright 2024 - Frankfurt Rights. All Right Reserved